European efforts to secure potential COVID-19 vaccines from Pfizer, Sanofi and Johnson & Johnson are mired in wrangles over price, payment method and potential liability costs, three EU officials told Reuters.
Exclusive: EU talks with Pfizer, Sanofi, J&J on COVID vaccines hit snags – sources
